Bayer

Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology

12 Aug 2025

Bayer AG Second Quarter 2025 Results and Media Update

06 Aug 2025

Bayer posts positive second quarter and progress on strategic priorities

06 Aug 2025

Bayer upgrades currency-adjusted sales and earnings guidance for 2025 and establishes additional provisions for litigation in the United States

01 Aug 2025

Bayer submits registration applications for novel herbicide in four major markets

30 Jul 2025

Bayer’s sevabertinib (BAY 2927088) accepted for review in China

28 Jul 2025

Bayer provides regulatory update on elinzanetant in the U.S.

28 Jul 2025

Bayer’s Nubeqa™ (darolutamide) receives EU approval in third indication for patients with advanced prostate cancer

22 Jul 2025

Supervisory Board of Bayer AG extends contract of CEO Bill Anderson

16 Jul 2025

Bayer to expand partnership with M2i Group to distribute pheromone-based biological crop protection solutions globally

16 Jul 2025

View details about the software product Informachine News Trackers